Fiche publication
Date publication
mai 2026
Journal
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Auteurs
Membres identifiés du Cancéropôle Est :
Pr PEYRIN-BIROULET Laurent
Tous les auteurs :
Hanzel J, Yuan Y, Goodwin SW, Nardone OM, Roseira J, Solitano V, Vuyyuru SK, Leong RW, Sands BE, Turner D, Moum B, Long MD, Louis E, Reinisch W, Rubin DT, Danese S, Dignass A, Siegel CA, Panaccione R, Dubinsky MC, Peyrin-Biroulet L, Halfvarson J, Magro F, Hart A, Jairath V,
Lien Pubmed
Résumé
Patient-reported outcomes (PROs) and outcome measures (PROMs) have increasing prominence in clinical trials for inflammatory bowel disease (IBD). This systematic review provides an overview of PROMs used in randomized controlled trial (RCTs), their placebo outcome rates, effect sizes, and operating properties.
Mots clés
Crohn’s disease, placebo, ulcerative colitis, validity
Référence
Clin Gastroenterol Hepatol. 2026 05 28;:
